These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31914797)

  • 21. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice.
    Pang J; David Marais A; Blom DJ; Brice BC; Silva PR; Jannes CE; Pereira AC; Hooper AJ; Ray KK; Santos RD; Watts GF
    Atherosclerosis; 2018 Oct; 277():470-476. PubMed ID: 30270087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population, aged 30-64 years.
    Rahman Al-Nuaim A
    Int J Cardiol; 1997 Dec; 62(3):227-35. PubMed ID: 9476683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and type of dyslipidaemia in a population at risk for cardiovascular death in Bulgaria.
    Temelkova-Kurktschiev TS; Kurktschiev DP; Vladimirova-Kitova LG; Vaklinova I; Todorova BR
    Folia Med (Plovdiv); 2009; 51(2):26-32. PubMed ID: 19670537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin Therapy and Risk of Diabetes Mellitus in Aging Patients With Heterozygous Familial Hypercholesterolemia or Familial Combined Hyperlipidemia: A 10-Year Follow-Up.
    Skoumas I; Ioakeimidis N; Vlachopoulos C; Chrysohoou C; Michalakeas C; Georgakopoulos C; Katsi V; Panagiotakos D; Tousoulis D
    Angiology; 2018 Mar; 69(3):242-248. PubMed ID: 28681648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of diabetes mellitus in Spanish primary care setting and its association with cardiovascular risk factors and cardiovascular diseases. SIMETAP-DM study.
    Ruiz-García A; Arranz-Martínez E; García-Álvarez JC; García-Fernández ME; Palacios-Martínez D; Montero-Costa A; Ciria-de-Pablo C; López-Uriarte B; García-Pliego RA; Chao-Escuer P; Zafra-Urango C; Alcaraz-Bethencourt A; Redondo-de-Pedro S; Escamilla-Guijarro N; Pascual-Val T; Vieira-Pascual MC; Martínez-Irazusta J; Martínez-Cid-de-Rivera E; Rodríguez-de-Cossío Á; de-Prado-Prieto L; Adrián-Sanz M; Minguela-Puras ME; Blanco-Canseco JM; Rubio-Villar M; Berbil-Bautista ML; Hueso-Quesada R; Plata-Barajas MT; Redondo-Sánchez M; Durán-Tejada MR; García-Redondo MR; Sánchez-Herráiz M; Rey-López AM; García-García-Alcañiz MP; Abad-Schilling C; Hidalgo-Calleja Y; Rivera-Teijido M;
    Clin Investig Arterioscler; 2020; 32(1):15-26. PubMed ID: 31130360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in phenotype, genotype and cardiovascular events between patients with probable and definite heterozygous familial hypercholesterolemia.
    Cao YX; Zhou BY; Sun D; Li S; Guo YL; Zhu CG; Wu NQ; Gao Y; Xu RX; Liu G; Dong Q; Li JJ
    Per Med; 2019 Nov; 16(6):467-478. PubMed ID: 31691639
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
    McCullough PA; Ballantyne CM; Sanganalmath SK; Langslet G; Baum SJ; Shah PK; Koren A; Mandel J; Davidson MH
    Am J Cardiol; 2018 Apr; 121(8):940-948. PubMed ID: 29472008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C.
    van Delden XM; Huijgen R; Wolmarans KH; Brice BC; Barron JK; Blom DJ; Marais AD
    Atherosclerosis; 2018 Oct; 277():327-333. PubMed ID: 30270067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and genetic characteristics of familial hypercholesterolemia patients with type 2 diabetes.
    Sun D; Cao YX; You XD; Zhou BY; Li S; Guo YL; Zhang Y; Wu NQ; Zhu CG; Gao Y; Dong QT; Liu G; Dong Q; Li JJ
    J Endocrinol Invest; 2019 May; 42(5):591-598. PubMed ID: 30276670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.
    Vishwanath R; Hemphill LC
    J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia.
    de Sauvage Nolting PR; Defesche JC; Buirma RJ; Hutten BA; Lansberg PJ; Kastelein JJ
    J Intern Med; 2003 Feb; 253(2):161-8. PubMed ID: 12542556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia.
    Gallo A; Charriere S; Vimont A; Chapman MJ; Angoulvant D; Boccara F; Cariou B; Carreau V; Carrié A; Bruckert E; Béliard S;
    Atherosclerosis; 2020 Aug; 306():41-49. PubMed ID: 32688103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia.
    Perez-Calahorra S; Laclaustra M; Marco-Benedí V; Lamiquiz-Moneo I; Pedro-Botet J; Plana N; Sanchez-Hernandez RM; Amor AJ; Almagro F; Fuentes F; Suarez-Tembra M; Civeira F;
    Atherosclerosis; 2019 May; 284():245-252. PubMed ID: 30827715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of heterozygous familial hypercholesterolemia and combined hyperlipidemia phenotype in very young survivors of myocardial infarction and their association with the severity of atheromatous burden.
    Rallidis LS; Kosmas N; Tsirebolos G; Rallidi M; Kiouri E; Kalpakos D
    J Clin Lipidol; 2019; 13(3):502-508. PubMed ID: 30956097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An online questionnaire survey of UK general practitioners' knowledge and management of familial hypercholesterolaemia.
    Kwok S; Pang J; Adam S; Watts GF; Soran H
    BMJ Open; 2016 Nov; 6(11):e012691. PubMed ID: 28186938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olive oil has a beneficial effect on impaired glucose regulation and other cardiometabolic risk factors. Di@bet.es study.
    Soriguer F; Rojo-Martínez G; Goday A; Bosch-Comas A; Bordiú E; Caballero-Díaz F; Calle-Pascual A; Carmena R; Casamitjana R; Castaño L; Castell C; Catalá M; Delgado E; Franch J; Gaztambide S; Girbés J; Gomis R; Gutiérrez G; López-Alba A; Teresa Martínez-Larrad M; Menéndez E; Mora-Peces I; Ortega E; Pascual-Manich G; Serrano-Rios M; Urrutia I; Valdés S; Antonio Vázquez J; Vendrell J
    Eur J Clin Nutr; 2013 Sep; 67(9):911-6. PubMed ID: 23859999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of drugs related to the treatment of diabetes mellitus and other cardiovascular risk factors in the Spanish population. The Di@bet.es study.
    Rojo-Martínez G; Valdés S; Colomo N; Lucena MI; Gaztambide S; Gomis R; Casamitjana R; Carmena R; Catalá M; Martínez-Larrad MT; Serrano-Ríos M; Castaño L; Vendrell J; Girbés J; Franch J; Vázquez JA; Mora-Peces I; Urrutia I; Pascual-Manich G; Ortega E; Menéndez E; Delgado E; Bordiú E; Castell C; López-Alba A; Goday A; Calle A; Bosch-Comas A; Soriguer F
    Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):854-63. PubMed ID: 24773992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus.
    Besseling J; Kastelein JJ; Defesche JC; Hutten BA; Hovingh GK
    JAMA; 2015 Mar; 313(10):1029-36. PubMed ID: 25756439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial hypercholesterolaemia commonly presents with Achilles tenosynovitis.
    Beeharry D; Coupe B; Benbow EW; Morgan J; Kwok S; Charlton-Menys V; France M; Durrington PN
    Ann Rheum Dis; 2006 Mar; 65(3):312-5. PubMed ID: 16176995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.